Skip to main content

Table 2 Susceptibility profile of Gram-positive bacilli and Gram-positive cocci isolated from human skin allografts with and without antimicrobial treatment

From: Bacterial contamination of human skin allografts and antimicrobial resistance: a skin bank problem

Gram-Positive Bacilli

Gram-Positive Cocci

Antimicrobial resistance profile

Number of isolates (n = 195)

Isolates

Treatment

Antimicrobial resistance profile

Number of isolates (n = 124)

Isolates

Treatment

WT

1ST

1ST/2ND

WT

1ST

1ST/2ND

PEN

CFO

27

1

B. cereus

B. subtilis

B. licheniformis

Bacillus sp.

B. vallismortis

2

1

9

3

1

12

PEN

CFO

AZM

20

1

13

S. aureus

S. lugdunensis

CNS

S. haemolyticus

CNS

19

1

12

1

1

PEN–CFO

CFO–EST

PEN–AZM

59

4

1

B. cereus

Paenibacillus sp.

B. cereus

28

2

4

—-

29

1

PEN–CIP

PEN–AZM

CIP–AZM

9

1

1

S. aureus

S. epidermidis

S. epidermidis

S. epidermidis

5

4

1

1

PEN–CFO–EST

PEN–CFO–AZM

10

1

B. cereus

Paenibacillus sp.

B. cereus

2

8

1

CFO–CIP–AZM

6

S. epidermidis

S. saprophyticus

5

1

PEN–CFO–CIP–AZM

54

S. epidermidis

S. capitis

S. saprophyticus

S. aureus

35

17

1

1

Susceptible to all ATM

92

Bacillus sp.

B. subtilis

B. vallismortis

B. pumilus

B. licheniformis

B. cereus

49

25

4

2

1

1

2

4

4

Susceptible to all ATM

19

S. haemolyticus

S. lugdunensis

4

15

  1. 1ST, isolates obtained from skin samples previously submitted to the first cycle of treatment with penicillin and streptomycin in the skin bank; 2ND, isolates obtained from skin samples previously submitted to the second cycle of treatment with vancomycin; ATM, antimicrobials; AZM, azithromycin; CFO, cefoxitin; CIP, ciprofloxacin; CNS, coagulase-negative staphylococci; EST, streptomycin; PEN, penicillin; WT, without treatment